Correlation Between Enlivex Therapeutics and ChitogenX

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and ChitogenX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and ChitogenX into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and ChitogenX, you can compare the effects of market volatilities on Enlivex Therapeutics and ChitogenX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of ChitogenX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and ChitogenX.

Diversification Opportunities for Enlivex Therapeutics and ChitogenX

0.17

Correlation Coefficient

Enlivex Therapeutics  ChitogenX

Average diversification

The 3 months correlation between Enlivex and ChitogenX is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and ChitogenX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChitogenX and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with ChitogenX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChitogenX has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and ChitogenX go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and ChitogenX

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the ChitogenX. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 5.35 times less risky than ChitogenX. The stock trades about -0.08 of its potential returns per unit of risk. The ChitogenX is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.51  in ChitogenX on December 4, 2024 and sell it today you would earn a total of  0.20  from holding ChitogenX or generate 39.22% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	93.65%
Values	Daily Returns

Enlivex Therapeutics  vs.  ChitogenX

Enlivex Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

ChitogenX

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ChitogenX are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ChitogenX reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enlivex Therapeutics and ChitogenX

The main advantage of trading using opposite Enlivex Therapeutics and ChitogenX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, ChitogenX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChitogenX will offset losses from the drop in ChitogenX's long position.

The idea behind Enlivex Therapeutics and ChitogenX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.